Skip to Main Content
Contact Us
Category: Early phase
Image of people around a table for the Best Practices for Operationalizing Global, Early-Phase Oncology Trials webinar Best Practices for Operationalizing Global, Early-Phase Oncology Trials The early-phase oncology clinical trial landscape is constantly evolving, influenced by shifts in regulatory guidance Read Now Trends and Challenges Blog Series-Growing Complexity of Conducting Oncology Trials The Growing Complexity of Conducting Oncology Trials Changing regulations, challenging study designs, and globalization Early-phase trial designs are becoming more complex following Read Now A female medical professional sits with a senior female patient. Early-Phase Oncology Research Expertise Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now Graphic with Highlights from AusBiotech 2024 Highlights from AusBiotech 2024 Australia Continues to Be Attractive Region for Oncology Trials AusBiotech, in Melbourne, Australia, hosted its Read Now Person at a computer with a bar chart being designed with a stylus. Impacts of Project Optimus on Oncology Trial Costs Exploring creative financial solutions for biotechs Navigating the evolving landscape of early-phase drug development has Read Now woman holds pills and capsules in her hands Ensure Your Oncology Program Is Project Optimus Ready What is Project Optimus? Project Optimus, an initiative from the U.S. Food and Drug Administration Read Now Multicolored pills on white background. FDA Finalizes Project Optimus Guidance for Dosing and Expectations for First-in-Human Oncology Trials The past 18 months have been Read Now Medical professional on the phone and at her computer. Traditional Site Networks Are Broken Building Real Site Relationships to Facilitate the Success of Early Phase Oncology Trials Oncology clinical Read Now Two young business people discussing a project. Rapid First Person In Milestone Less than 2 months for an oncology drug and device development company A drug and Read Now Optimizing Outcomes with Pharmacokinetics (PK) Advancing Oncology Therapeutics Pharmacokinetic endpoints have always been important, but recent U.S. Food and Drug Read Now